Veopoz: The First FDA-approved Treatment for CHAPLE Disease
The U.S. Food and Drug Administration (FDA) has announced its approval for the innovative drug, Veopoz (pozelimab-bbfg) [1,2], making it the inaugural approved remedy for CHAPLE disease, which affects both adults and children over one year of age.
What is CHAPLE Disease?
CHAPLE [3], an acronym for complement